Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Surface Oncology, Inc. (SURF)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
0.9715+0.0015 (+0.15%)
At close: 04:00PM EST
1.0100 +0.04 (+3.96%)
After hours: 07:19PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close0.9700
Open0.9901
Bid0.9751 x 2200
Ask1.0100 x 1200
Day's Range0.9511 - 1.0100
52 Week Range0.6020 - 3.8100
Volume164,715
Avg. Volume312,433
Market Cap58.817M
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-1.2330
Earnings DateFeb 28, 2023 - Mar 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SURF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Surface Oncology, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    11 hours agoMorningstar
View more
Advertisement
Advertisement